ATAI
NasdaqGMAtaiBeckley Inc.
Price
Key statistics
Insider activity
SEC EDGAR ↗Showing 21 recent filings. 18 other (grants, option exercises, gifts, tax withholding) are listed below but excluded from buy/sell flow.
| Insider | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|
HERSHBERG ROBERT Director | Option exercise | 48.86K | $1.35 | $65,958.30 | 2026-07-07 |
HERSHBERG ROBERT Director | Option exercise | 51.14K | $1.35 | $69,041.70 | 2026-07-07 |
HERSHBERG ROBERT Director | Sell (open market) | 100K | $4.96 | $496,000.00 | 2026-07-07 |
HERSHBERG ROBERT Director | Option exercise | 48.86K | $0.00 | — | 2026-07-07 |
HERSHBERG ROBERT Director | Option exercise | 51.14K | $0.00 | — | 2026-07-07 |
Craig Kevin James Chief Medical Officer | Option exercise | 33.05K | $1.50 | $49,576.50 | 2026-06-25 |
Craig Kevin James Chief Medical Officer | Option exercise | 9.53K | $1.18 | $11,243.04 | 2026-06-25 |
Craig Kevin James Chief Medical Officer | Sell (open market) | 42.58K | $4.51 | $192,031.29 | 2026-06-25 |
Craig Kevin James Chief Medical Officer | Option exercise | 33.05K | $0.00 | — | 2026-06-25 |
Craig Kevin James Chief Medical Officer | Option exercise | 9.53K | $0.00 | — | 2026-06-25 |
Kochendoerfer Gerd Chief Operating Officer | Option exercise | 50K | $1.60 | $80,000.00 | 2026-06-26 |
Kochendoerfer Gerd Chief Operating Officer | Sell (open market) | 50K | $5.00 | $250,000.00 | 2026-06-26 |
Kochendoerfer Gerd Chief Operating Officer | Option exercise | 50K | $0.00 | — | 2026-06-26 |
Angermayer Christian Director, 10% Owner | Grant / award | 121.97K | $0.00 | — | 2026-06-04 |
Braunstein Scott Director | Grant / award | 121.97K | $0.00 | — | 2026-06-04 |
Braunstein Scott Director | Grant / award | 86.1K | $0.00 | — | 2026-06-04 |
Fischer Laurent Director | Grant / award | 121.97K | $0.00 | — | 2026-06-04 |
HERSHBERG ROBERT Director | Grant / award | 121.97K | $0.00 | — | 2026-06-04 |
Hoffman John Francis Director | Grant / award | 121.97K | $0.00 | — | 2026-06-04 |
Kalali Amir H Director | Grant / award | 121.97K | $0.00 | — | 2026-06-04 |
Smiley Andrea Heslin Director | Grant / award | 121.97K | $0.00 | — | 2026-06-04 |
Source: SEC EDGAR Forms 4/4A (CIK 2081043). Click an insider to open the original filing.
Social sentiment
Volume-weighted across live social sources
@PubMed @Horseman23 if thats the case why would $ATAI sell out early? Read between the lines. Who’s holding on to their assets? Who’s closest to approval? I’m not worries in the slightest. Ask anyone following these stocks and nobody can understand why $CMPS is trading below $ATAI buy out price or below $DFTX market cap. Time will tell.
$CMPS $DFTX $ATAI CMPS buyout coming before year's end at between 5 and 6 billion.
$HELP similar setup to $ATAI expect 30+
@leLu83 I’m going to mute this guy now. Zero interest posts already starting from $ATAI times. Do you really think you can move the stocks up or down by these posts?
$ATAI https://www.forbes.com/sites/willyakowicz/2026/07/24/this-billionaire-made-360-million-selling-his-psychedelic-company-to-eli-lilly/
$CMPS I think the biggest short-term risk is what ends up being in the proxy statement for the $ATAI sale. In it, we’ll see ATAI/Lilly’s justification for why $2.8-$3.8BN was a fair price for the company. If the low (IMO) valuation is based on a persuasive argument that there’s a much more limited market for TRD psychedelics than we’re considering or significant concerns about reimbursements, that could hurt this stock until we prove otherwise.
@1TimeDealer This moron HATES making money. He obviously is hating his decision on $ATAI because he always talked about it going to $50 and how $CMPS and $DFTX was dead. I would post his old comments under his shit talking posts until he blocked me. 😂😂😂
$ATAI after deal closes. Theres an easy parlay from here. Silver linings are some of the sweetest kickers of the whole thing.
@Millionaire11 @leLu83 Was all in for $ATAI , disappointed with the payout and now lashing out. Won't change the past.
$HELP watch this get bought up just like $ATAI both have a similar pipeline
$ATAI https://www.illusionconsensus.com/p/exclusive-why-eli-lilly-chose-atai
This month, I’m watching… 5 stocks with strong potential heading into 2027. The focus is simple: finding companies with improving momentum, early market attention, and asymmetric upside potential. My watchlist: $VEEE + 400% ~ 450% $SOBR + around 100% $WBUY +70% ~ 80% $CRNX + 50% ~ 60% $ATAI + 40% ~ 50% Not every stock will follow the same path, but the biggest moves often start when fewer people are paying attention. The market rewards preparation, patience, and being early. Next alert is coming soon. If you’re not following with notifications on, you’re likely seeing the move after it already happened.
Latest news
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva
How Much Upside is Left in AtaiBeckley Inc (ATAI)? Wall Street Analysts Think 33.33%
AtaiBeckley acquisition highlights growing Big Pharma interest in psychedelics
AtaiBeckley (ATAI) After Eli Lillys Bid Still Looks Fully Valued
Eli Lilly's $3.8bn psychedelics bet is built on British science
AtaiBeckley (ATAI) Soars to 4-Year High on $3.8B Merger with Eli Lilly
Eli Lilly Trips Into Red-Hot Psychedelics Space With A Big Takeover
Sector Update: Healthcare Stocks Gain Late Afternoon
AtaiBeckley Soars as Eli Lilly Agrees to $2.8 Billion Buyout
Get insider-buy alerts
Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.